Oncologists most likely to feel effects of new program
Some physicians are optimistic about Medicare's Competitive Acqui-sition Program, in which at least two contractors per area negotiate with drug-makers to provide drugs to physician offices.
Many physicians have expressed doubts about the CAP program, in which you'll choose between billing for drugs yourself or allowing a vendor to supply the drugs and bill Medicare directly. As proposed, the CAP will require physicians to know which patient will receive which dose of a drug - and on which date. (See PBI, Vol. 6, No. 19).
But 27 percent of physicians said they felt positively about the CAP, and the majority felt neutral, according to a survey released June 2 by Health Products Research, a division of Somerset, NJ-based Ventiv Health.
Physicians said the CAP could increase drug availability to patients and would most likely impact oncology products the most.
Cardiovascular agents, rheumatalgics, antibiotics and injectables could also benefit, physicians say.
CMS officials said in the physician ODF that they've removed the note that prevented you from billing Q3001 and the carriers should accept the new code instead of 79900. Also, even though a recent transmittal on the use of Q3001 mentioned ambulatory surgery centers specifically, you should use Q3001 in other settings as well, CMS officials noted.